MT3 and glioblastoma: Analysis showed the trend for increasing MT1A, MT1E, MT1X, MT2 and MT3 gene expression in higher malignancy tumours, e.g. glioblastomas as compared to I-III grade astrocytomas (Figs 1a,c,e, 2a,c).